Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey

Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study

“…In a survey conducted by Horn et al [15] in 1,657 patients with moderate to severe psoriasis, 40% of respondents reported no current treatment at the time of their disease, and less than 50% with severe psoriasis were receiving systemic therapy with a biologic or phototherapy as recommended by the guidelines. In a study published by Armstrong et al [29], a total of 5,604 patients with psoriasis or PsA were surveyed.…”

“…Although surveys indicate that patients may frequently remain under ineffective treatment for longer than necessary [7,14,15,16], only few studies have analysed patient satisfaction with health care provision in psoriasis [17,18,19,20]. In the Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) study, van de Kerkhof et al [12] showed that approximately 40% of dermatologists were comfortable, but conservative, in their use of biologic therapy.…”

Ten Years On

“…12 Evidence, however, continues to accumulate to support that the full potential of these magic bullets has not been realized because patients continue to be considerably undertreated globally. [13][14][15] In a series of US surveys performed by the National Psoriasis Foundation from 2003 to 2011, the proportion of patients with moderate to severe psoriasis who remain untreated has plateaued at approximately 30%. 13 Moreover, more than 20% of patients with moderate to severe psoriasis continue to be treated with topical therapies alone and more than 50% of patients are dissatisfied with their treatment.…”

“…[13][14][15] In a series of US surveys performed by the National Psoriasis Foundation from 2003 to 2011, the proportion of patients with moderate to severe psoriasis who remain untreated has plateaued at approximately 30%. 13 Moreover, more than 20% of patients with moderate to severe psoriasis continue to be treated with topical therapies alone and more than 50% of patients are dissatisfied with their treatment. 14 In Brazil, similar discrepancies exist between actual clinical practice and the recommendations included in the relevant guidelines, thus negatively influencing optimal patient care.…”

The International Psoriasis Council: Advancing Knowledge, Enhancing Care

“…In a National Psoriasis Foundation survey of patients with severe psoriasis, 26% were treated with systemic therapy, phototherapy, or both; 39% were not in treatment, and 35% were treated with topical therapy alone. 8 Guidelines are available for the diagnosis and management of psoriasis and the identification of comorbidities. Immunomodulatory and biologic drugs are currently recommended in these guidelines for patients with moderate to severe psoriasis and/or psoriatic arthritis.…”